# NCT06610344 (NCT06610344)

> BHB & CAR-T for Lymphomas

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06610344
- Phase: NA
- Status: RECRUITING
- Sponsor: Abramson Cancer Center at Penn Medicine
- Conditions: Large B-cell Lymphoma
- Interventions: R-1,3-Butanediol
- Enrollment: 5
- Primary outcome: Safety and tolerability

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- Bluesky threads: 2
- X threads: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct06610344